Track topics on Twitter Track topics that are important to you
Moleculin Biotech (NASDAQ: MBRX) Founder, President and CEO Walter Klemp sat down with Christine Corrado from Proactive Investors New York to talk about their company that is looking for treatments for some of the toughest cancers to fight including Pancreatic.
Klemp telling Proactive, Moleculin has just raised 15 million dollars which will allow them to continue their trials for the next 18 months/
Original Article: Moleculin Biotech looks to treat worlds toughest cancers with therapiesNEXT ARTICLE
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...
The pancreas secretes a number of important hormones into the digestive tract and the blood stream. Cancers are most commonly exocrine than endocrine (neuroendocrine) tumors. Functional tumors secrete hormones; Insulinoma, Gastrinoma, Somatostatinoma, VI...